Skip to main content
logo
Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
8.97
+1.73 (23.90%)
At close: Aug 13, 2025

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2005 - 2019
Medical Pharmaceuticals
398.83B
Log In
Log In
Log In
Log In
Upgrade
Medical Pharmaceuticals Growth
26.79%
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2005 - 2019
North America
251.81B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
58.34%
Log In
Log In
Log In
Log In
Upgrade
Japan
99.84B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
-12.92%
Log In
Log In
Log In
Log In
Upgrade
Asia
47.18B
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
15.46%
Log In
Log In
Log In
Log In
Upgrade
Global
-
Log In
Log In
Log In
Log In
Upgrade
Global Growth
-
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade
China Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Overseas
-
Log In
Log In
Log In
Log In
Upgrade
Other Overseas Growth
-
Log In
Log In
Log In
Log In
Upgrade